https://www.marketscreener.com/quote/stock/NOVOCURE-LIMITED-24157014/news/Novocure-s-Optune-Approved-in-Canada-for-the-Treatment-of-Newly-Diagnosed-and-Recurrent-Glioblas-42428001/?utm_source=telegram&utm_medium=social&utm_campaign=share